Occurrence and Control of Polar Persistent Pollutants (P3) in Urban Wastewater
Occurrence and Control of Polar Persistent Pollutants (P3) in Urban Wastewater
批准号:
16360263
负责人:
TANAKA Hiroaki
金额:
$9.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Pharmaceutical and personal care products (PPCPs) including medical drugs and cosmetics are commonly used in daily life, which are being recognized emerging pollutants causing potential environmental issues. Most of them are less biodegradable and polar to some extent called "Persistent Polar Pollutant(P3)" which am expected to be less effectively removed during conventional wastewater treatment.This study mainly focused on the commence and reduction of PPCPs in sewage treatment where most of domestic wastewater axe collected because they are deemed to be their major portal site to the water environment. In addition this study she focused on initial risk evaluation of PPCPs associated with wastewater in sewage treatment based on their ea: don-laity data and on their biodegradability by batch experiment using activated sludge.SPE-LC/MS/MS method far measurement of PPCPs in sewage and sludge were applied for a few selected antibiotics at the early stage and for around 50 PPCPs at the fin … More al stage in this study. From the results of influent sewage, many PPCPs were detected and wets found to range at the order of 10ng/L to 10μg/L. Caffeine (10μg/L), acetaminophen (8.4μg/L.), bezafibrate (2.7μg/L), theophylline (2.0μg/L), clarithromycin (1.4μg/L), sulpiride(1.1μg/L) etc. occurred at higher concentrations. Their removal efficiencies ranged 30-100% during conventional biological treatment, which indicated removal efficiencies greatly depend on characteristics of PPCPs. Around 80 % of reduction of PPCPs residing in secondary effluent could be expected by ozonation following biological treatment for many PPCPs, but disopiramide and ketoprofen were less effectively removed as low as 60% even by ozonation, which resulted in 100ng/L or more concentration after ozonation. Risk quotient that can be calculated from MEC/NOEC based on algal growth inhibition test was evaluated during wastewater treatment. The risk quotient of each PPCP exceeded one in influent sewage and decreased to less than 1 after biological treatment, and finally decreased to 0.1 after oznation. When batch treatment of PPCPs using activated sludge was conducted, PPCP concentrations in water were monitored. The difference in elimination rates of their concentrations between common activated sludge and that manipulated for inactivation can be assumed apparent biodegradability. Reduction of PPCPs in water seemed to be afflicted by biodegradability for many PPCPs, but less for antibiotics and germicides. Positive relationship between reduction of PPCPs in the actual sewage process and their apparent biodegradability was observed. Less
期刊论文(85)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
凝集剤添加活性汚泥法によるヒト用抗生物質の除去効果
添加絮凝剂活性污泥法去除人体抗生素效果
DOI:
--
发表时间:
2006
期刊:
用水と排水 48
影响因子:
--
作者:
[小林義和, 山下尚之, 田中宏明]
通讯作者:
田中宏明
凝集剤を用いた下水処理での医薬品の除去効果の把握
了解使用混凝剂进行污水处理中药物去除的有效性
DOI:
--
发表时间:
2006
期刊:
第40回日本水環境学会年会講演集 40
影响因子:
--
作者:
[小林, 田中, 八十島, 小森, 鈴木]
通讯作者:
鈴木
Study on Removal Effect of Pharmaceuticals by the Wastewater Treatment using Chemical Coagulants
化学混凝剂处理废水中药物去除效果的研究
DOI:
--
发表时间:
2006
期刊:
影响因子:
--
作者:
[Y., Kobayashi, H., Tanaka, M., Yasojima, K., Komori, Y., Suzuki]
通讯作者:
Suzuki
環境水中に存在する抗生物質を対象とした藻類成長阻害試験
针对环境水中存在的抗生素的藻类生长抑制测试
DOI:
--
发表时间:
2005
期刊:
影响因子:
--
作者:
[清水大吾、山下尚之、田中宏明, 鈴木穣]
通讯作者:
鈴木穣
DOI:
10.2166/wst.2006.357
发表时间:
2006-05
期刊:
Water science and technology : a journal of the International Association on Water Pollution Research
影响因子:
--
作者:
[M. Yasojima;N. Nakada;K. Komori;Y. Suzuki;H. Tanaka]
通讯作者:
M. Yasojima;N. Nakada;K. Komori;Y. Suzuki;H. Tanaka
共 52 条
G.A.I.Tを用いた脳卒中患者に対する歩行評価の有用性の検証
-
批准号:22H04396
-
项目类别:Grant-in-Aid for Encouragement of Scientists
-
资助金额:$0.29万
-
财政年份:2022
-
负责人:TANAKA Hiroaki
-
依托单位:
Science and Technology Mobilization from the Viewpoint of Industrial Circles: A Study Surveying the Documents of Ishikawa Ichiro
-
批准号:15K01122
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2015
-
负责人:TANAKA Hiroaki
-
依托单位:
Development and system construction of exercise protocol that contributes to health lifetime extension and elderly care prevention
-
批准号:25242065
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$29.87万
-
财政年份:2013
-
负责人:TANAKA Hiroaki
-
依托单位:
Developing and Applying Motivational Strategies: Qualitative Research
-
批准号:25770217
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.25万
-
财政年份:2013
-
负责人:TANAKA Hiroaki
-
依托单位:
Comparison of endrine disruption activities of urban wastewater by reporter gene assay considering difference in speices sensitivities
-
批准号:23254003
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$34.03万
-
财政年份:2011
-
负责人:TANAKA Hiroaki
-
依托单位:
Estimation and mechanism on reduction of emerging contaminants in wastewater treatment
-
批准号:23360234
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.15万
-
财政年份:2011
-
负责人:TANAKA Hiroaki
-
依托单位:
The study of safe and efficacious for exercise prescription andassessment of cardiac performance determine with heart sound.
-
批准号:22300240
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.81万
-
财政年份:2010
-
负责人:TANAKA Hiroaki
-
依托单位:
Study on high accuracy large satellite antenna surface
-
批准号:22760631
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.58万
-
财政年份:2010
-
负责人:TANAKA Hiroaki
-
依托单位:
Impact of PSK and DT on peptide vaccine against gastrointestinal cance
-
批准号:22591466
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2010
-
负责人:TANAKA Hiroaki
-
依托单位:
Social effect analysis on securitization of risk and its optimal management from an engineering viewpoint
-
批准号:21560066
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2009
-
负责人:TANAKA Hiroaki
-
依托单位:
Enhancing low-motivated learners: From the viewpoint of individual differences
-
批准号:21720215
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.25万
-
财政年份:2009
-
负责人:TANAKA Hiroaki
-
依托单位:
Evaluation and Control of Water Pollution due to Residual Pharmaceuticals Suspected High Risk on Aquatic Ecosystems
-
批准号:20360240
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.15万
-
财政年份:2008
-
负责人:TANAKA Hiroaki
-
依托单位:
Comparative study between Japan and the UK on pollution due to estrogens in the river environment and its countermeasures
-
批准号:19404004
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.23万
-
财政年份:2007
-
负责人:TANAKA Hiroaki
-
依托单位:
Impact of TGFbeta Inhibitor on dendritic cells and vaccine therapy for gastric cancer
-
批准号:19790948
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.25万
-
财政年份:2007
-
负责人:TANAKA Hiroaki
-
依托单位:
Developing "Navigation Database" of motivational strategies : focusing on individual differences
-
批准号:19820051
-
项目类别:Grant-in-Aid for Young Scientists (Start-up)
-
资助金额:$0.9万
-
财政年份:2007
-
负责人:TANAKA Hiroaki
-
依托单位:
Development of an Exercise Program based on Gene/Protein expression and Metabolic Response during Exercise
-
批准号:19200049
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$31.95万
-
财政年份:2007
-
负责人:TANAKA Hiroaki
-
依托单位:
Construction of an integrated risk theory and its applications to real option problems
-
批准号:18560061
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.44万
-
财政年份:2006
-
负责人:TANAKA Hiroaki
-
依托单位:
Construction and Evaluation of Service Learning Model in Cooperation with Miyazaki Region
-
批准号:17500649
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:2005
-
负责人:TANAKA Hiroaki
-
依托单位:
Molecular biological studies of skeletal muscle adaptations to physical exercise
-
批准号:15200050
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$28.29万
-
财政年份:2003
-
负责人:TANAKA Hiroaki
-
依托单位:
Application of a Fast Simulation Scheme Having a Wide Applicability to Some Practical Fields Including Information Technologies
-
批准号:13650065
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2001
-
负责人:TANAKA Hiroaki
-
依托单位:
海外基金